Related Experiment Video
Updated: Mar 17, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Necroptosis: A new way of dying?
1a Department of Molecular Medicine and Haematology, Faculty of Health Sciences , University of the Witwatersrand , Johannesburg , South Africa.
Abstract:
This review embarks upon a cell death journey from the discovery of apoptosis and necrosis through to the coalescence of these: necroptosis. The mechanisms of 2 emerging necrotic cell death pathways, pyroptosis and ferroptosis, will be explored before delving into apoptotic and necroptotic signaling cascades, highlighting the complex interplay between molecular players. The involvement of the ripoptosome, interferon signaling and DNA damage in necroptosis will be discussed briefly. The major focus is on necroptosis initiation by tumor necrosis factor-α (TNFα) and its cognate receptor TNFR1, caspase-independent RIP1/RIP3/MLKL necrosome activation and cell death propagation by damage-associated molecular pattern (DAMP) release. Finally, the implications of a complex cell death signaling network will be revealed in the context of cancer biology and therapy. The clinical contribution of the discovery of necroptosis as an unequivocally new way of dying is monumental and could drastically alter cancer therapy strategies in the future.
Insights
This review explores cell death mechanisms, focusing on necroptosis (programmed necrosis). Understanding necroptosis initiation and signaling is crucial for developing novel cancer therapies.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Apoptosis and necrosis are well-defined cell death types.
- Emerging necrotic pathways include pyroptosis and ferroptosis.
- Necroptosis represents a distinct programmed necrosis pathway.
Purpose of the Study:
- To review the discovery and mechanisms of necroptosis.
- To explore the signaling cascades of apoptosis and necroptosis.
- To highlight the role of necroptosis in cancer biology and therapy.
Main Methods:
- Literature review of cell death pathways.
- Analysis of molecular players in apoptotic and necroptotic signaling.
- Discussion of necroptosis initiation via TNFα/TNFR1 and RIPK1/RIPK3/MLKL activation.
Main Results:
- Necroptosis is a caspase-independent programmed necrosis.
- TNFα/TNFR1 signaling initiates necroptosis through RIPK1/RIPK3/MLKL complex formation.
- DAMP release propagates necroptosis, influencing the tumor microenvironment.
Conclusions:
- Necroptosis is a critical cell death pathway with significant implications for cancer.
- Targeting necroptosis offers a promising strategy for cancer therapy.
- The discovery of necroptosis could revolutionize cancer treatment approaches.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Extrinsic Apoptotic Pathway
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

